# SignaCor Therapeutics

**Source:** https://www.startuphub.ai/startups/signacor-therapeutics
**Profile type:** Startup

> Clinical-stage drug development company advancing treatments for hypertrophic cardiomyopathy and cardiovascular health.

## About

SignaCor Therapeutics is a clinical-stage drug development company spun out from Queen's University Belfast. They are developing first-in-class therapies for symptomatic hypertrophic cardiomyopathy (HCM) that target underlying disease pathology to reverse heart damage and improve patient outcomes.

## Key facts

- **Slug:** signacor-therapeutics
- **Location:** Belfast, United Kingdom
- **Founded:** 2024-01-01
- **Operating status:** Active
- **Total funding:** $315K
- **Sectors / tags:** HealthTech, Biotechnology, Cardiovascular Health, Cardiovascular

## Frequently asked

### What does SignaCor Therapeutics do?

SignaCor Therapeutics is a clinical-stage drug development company spun out from Queen's University Belfast. They are developing first-in-class therapies for symptomatic hypertrophic cardiomyopathy (HCM) that target underlying disease pathology to reverse heart damage and improve patient outcomes.

### What is SignaCor Therapeutics's revenue?

StartupHub estimates SignaCor Therapeutics's annual revenue at $53K (range $26K to $188K, 31% confidence), based on comparable companies in the sector.

### What is SignaCor Therapeutics's valuation?

StartupHub estimates SignaCor Therapeutics's effective valuation at $1.2M (range $788K to $1.9M, 22% confidence), based on comparable companies in the sector.

### How much funding has SignaCor Therapeutics raised?

SignaCor Therapeutics has raised a total of $315K in funding. The most recent round on record is Seed.

### Where is SignaCor Therapeutics headquartered?

SignaCor Therapeutics is headquartered in Belfast, United Kingdom.

### When was SignaCor Therapeutics founded?

SignaCor Therapeutics was founded in 2024.

### What industry does SignaCor Therapeutics operate in?

SignaCor Therapeutics operates in HealthTech, Biotechnology, Cardiovascular Health, Cardiovascular.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "SignaCor Therapeutics",
          "item": "https://www.startuphub.ai/startups/signacor-therapeutics"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/signacor-therapeutics#webpage",
      "url": "https://www.startuphub.ai/startups/signacor-therapeutics",
      "name": "SignaCor Therapeutics - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of SignaCor Therapeutics. SignaCor Therapeutics is a startup founded in 2024, operating in HealthTech and Biotechnology. Clinical-stage drug development company advancing treatments for hypertrophic cardiomyopathy and cardiovascular health. Headquartered in Belfast, United Kingdom.",
      "dateModified": "2026-08-01T06:00:05.177+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/signacor-therapeutics#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/signacor-therapeutics#organization",
      "name": "SignaCor Therapeutics",
      "url": "https://www.startuphub.ai/startups/signacor-therapeutics",
      "description": "This is the official profile of SignaCor Therapeutics. SignaCor Therapeutics is a startup founded in 2024, operating in HealthTech and Biotechnology. Clinical-stage drug development company advancing treatments for hypertrophic cardiomyopathy and cardiovascular health. Headquartered in Belfast, United Kingdom.",
      "sameAs": [
        "https://www.startuphub.ai/startups/signacor-therapeutics"
      ],
      "foundingDate": "2024-01-01",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Belfast",
        "addressCountry": "GB"
      },
      "knowsAbout": [
        "HealthTech",
        "Biotechnology",
        "Cardiovascular Health",
        "Cardiovascular"
      ]
    }
  ]
}
```